Healthcare Providers and Services
Company Overview of EKR Therapeutics, Inc.
As of June 26, 2012, EKR Therapeutics, Inc. was acquired by Cornerstone Therapeutics Inc. EKR Therapeutics, Inc. operates as a specialty pharmaceutical company and identifies, commercializes, and markets products to acute-care hospitals. The company offers acute-care and oncology supportive care therapeutic products, including nicardipine hydrochloride, morphine sulfate extended-release liposome injection, and reteplase, recombinant. It serves hospital administrators and healthcare providers in the United States. The company was founded in 2005 and is based in Bedminster, New Jersey.
1545 US Highway 206
Bedminster, NJ 07921
Founded in 2005
Key Executives for EKR Therapeutics, Inc.
EKR Therapeutics, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|St. Vincent Medical Center, Inc.||United States|
|Elite Dental Partners LLC||United States|
|Bayshore Dialysis Center||United States|
|Commercial/Medical Electronics, Inc.||United States|
|Personalized Cancer Therapy, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact EKR Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.